With support from Unitaid and working with national and provincial partners, the World Health Organization (WHO) is helping strengthen the skills, equipment and services needed to screen women, detect precancerous lesions and provide timely treatment closer to where they live.
Cervical cancer takes a heavy toll on women and families in Papua New Guinea (PNG). More than 1,000 women are diagnosed each year and approximately 650 dies from the disease, making it the leading cause of cancer deaths among women in the country. Yet cervical cancer is largely preventable.
PNG has launched human papillomavirus (HPV) vaccination to protect girls against cervical cancer later in life. The introductory phase will target girls aged 9–14 years, with Phase 1 planned for the National Capital District before gradual expansion to other provinces. After the introductory phase, the programme will target 9-year-olds. While vaccination protects the next generation, screening and timely treatment remain essential for women today.
Building provincial capacity
For many women in PNG, accessing cervical cancer services has historically meant travelling long distances, waiting months for specialist care or, in some cases, not receiving care at all.
Josephine Gabuzzi, Cervical Cancer Screening Project Coordinator at Western Highlands Provincial Health Authority (PHA), remembers when Pap smear samples had to be sent overseas for testing: “Initially, when we started in 2013, we did Pap smears and most of the slides were sent to Australia. Women waited five to six months for their results, and some of them died from cervical cancer before receiving them."
Today, PNG is working to change this.
With support from Unitaid, WHO is helping strengthen cervical cancer screening, diagnosis and treatment services across the country. Working with the National Department of Health (NDoH), PHAs, the Kirby Institute, the Obstetrics & Gynaecology Society of Papua New Guinea and other partners, the initiative is investing in the people, equipment and approaches needed to provide services closer to women.
Twenty-four health workers have been trained in HPV Screen-and-Treat, colposcopy and large loop excision of the transformation zone (LLETZ). The training has strengthened provincial capacity to screen women, investigate abnormalities and treat precancerous lesions. They come from Hela, Milne Bay, New Ireland, Southern Highlands and Western Highlands provinces, and from Port Moresby General Hospital (PMGH) in the National Capital District.
Health workers practise clinical skills during a training session. Photo credit: WHO
But training alone does not create a service.
With Unitaid support, WHO has also provided critical equipment and supplies, including colposcopes, LLETZ machines and essential consumables. This support is intended to strengthen diagnostic and treatment capacity in the participating provinces and at PMGH.
Health workers participate in a ceremonial handover of equipment at Hagen Provincial Hospital. Photo credit: WHO, Papua New Guinea
The importance of these investments is not simply in the number of health workers trained or machines delivered. It is in what provincial teams can increasingly do: identify women at risk and treat precancerous lesions before they develop into cervical cancer.
Turning capacity into care
Building sustainable services also means helping women understand when and where to seek care.
In Milne Bay, community awareness activities reached more than 200 people within the first month, helping women understand the importance of screening, early detection and treatment.
A health worker engages with community members during a community awareness activity. Photo credit: Milne Bay Provincial Health Authority
One health worker described what happened when her team returned from training: “Women were not aware of the services we provided. But after training, we went out and did awareness activities, and many of them came. They were happy that they could know their HPV status and receive help early, and women are still coming.”
This is where investment in the health system begins to translate into change: provincial teams equipped with the skills, tools and confidence to provide services; communities that understand why screening matters; and women able to receive earlier diagnosis and treatment closer to home.
Building towards cervical cancer elimination
The scale of the challenge remains significant. Project estimates indicate that more than 200,000 women in participating provinces will need access to HPV screening services by 2030 to achieve WHO screening targets, with more than 30,000 women projected to require treatment or specialist referral for cervical precancerous lesions.
Reaching women at this scale will require continued investment in skilled health workers, equipment, consumables, community engagement and reliable service delivery.
But the ultimate measure of progress will not be the number of training sessions conducted or machines delivered. It will be whether provincial teams can confidently deliver quality services; women can access screening near them and receive their results without unnecessary delays; precancerous lesions can be identified and treated before they become cancer; and more women can receive the care they need closer to home.
This work is made possible by funding from the Government of Japan through Unitaid. WHO and the Kirby Institute have driven its technical design and on-ground support and coordination. Together, these partners are helping Government of Papua New Guinea to move cervical cancer elimination from ambition to reality and to bring better care to women across PNG.